Bank Of New York Mellon Corp Regeneron Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $695 Million - $754 Million	984,472 New	984,472 $710 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $37.2 Million - $47 Million	64,867 Added 6.77%	1,022,724 $705 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $22.4 Million - $30.1 Million	40,799 Added 4.45%	957,857 $566 Million
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $19.7 Million - $23.1 Million	33,036 Added 3.74%	917,058 $640 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $1.74 Million - $2.15 Million	3,207 Added 0.36%	884,022 $558 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $12.7 Million - $15.1 Million	22,199 Added 2.59%	880,815 $533 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $5.95 Million - $7.03 Million	12,578 Added 1.49%	858,616 $480 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $7.94 Million - $9.74 Million	17,774 Added 2.15%	846,038 $400 Million
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $3.89 Million - $4.95 Million	8,138 Added 0.99%	828,264 $400 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $25.6 Million - $30.9 Million	46,975 Added 6.08%	820,126 $459 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $79.2 Million - $103 Million	160,589 Added 26.22%	773,151 $482 Million
Q1 2020 May 06, 2020	BUY	$336.18 - $494.43 $4 Million - $5.88 Million	11,889 Added 1.98%	612,562 $299 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $27,687 - $38,027	-101 Reduced 0.02%	600,673 $226 Million
Q3 2019 Nov 07, 2019	SELL	$273.46 - $318.39 $555,670 - $646,968	-2,032 Reduced 0.34%	600,774 $167 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $771,769 - $1.07 Million	-2,576 Reduced 0.43%	602,806 $189 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $5.04 Million - $5.95 Million	13,539 Added 2.29%	605,382 $249 Million
Q4 2018 Feb 11, 2019	SELL	$335.82 - $403.04 $4.4 Million - $5.28 Million	-13,101 Reduced 2.17%	591,843 $221 Million
Q3 2018 Nov 09, 2018	BUY	$351.14 - $408.51 $2.64 Million - $3.07 Million	7,520 Added 1.26%	604,944 $0
Q2 2018 Aug 06, 2018	BUY	$284.6 - $344.99 $300,253 - $363,964	1,055 Added 0.18%	597,424 $206 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $6.96 Million - $8.68 Million	-22,041 Reduced 3.56%	596,369 $205 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $222 Million - $291 Million	618,410	618,410 $232 Million

Others Institutions Holding REGN

# of Institutions

1,493

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

Vanguard Group Inc Valley Forge, PA

9.29M
Shares

$6.49 Billion
0.12% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$5.9 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

7.06M
Shares

$4.93 Billion
0.41% of portfolio
State Street Corp Boston, MA

4.83M
Shares

$3.38 Billion
0.14% of portfolio
Capital International Investors Los Angeles, CA

4.74M
Shares

$3.31 Billion
0.66% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account